Silica-assisted solid-phase peptide synthesis improves solvent efficiency in peptide synthesis, suggesting effective strategies for producing high-purity peptides.
Non‐swelling silica‐based resin was used for peptide synthesis. The strategy used is similar to that of solid‐phase peptide synthesis (SPPS), referred to as silica‐assisted solid‐phase peptide synthesis (SiPPS). A 2‐h coupling seemed to favor the coupling compared to that of 1‐h standard coupling. The use of this non‐swelling resin allows a 50% reduction in the consumption of solvents. The strategy was well demonstrated for the synthesis of H‐YSSFL‐NH 2 , linear oxytocin, angiotensin II, and afamelanotide using a silica‐based support (Fmoc‐Rink amide SiliaBond manufactured from SiliCycle Inc.). The peptides were found to have more than acceptable purity, although there was a loss in overall yields.
No takes yet. Share an insight, caveat, or question.
Nkwanyana et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: